|
Table of Contents
NARMS
Public Meetings
CVM Updates
Framework Document
VMAC Testimony
|
| |
Latest Information:
|
Animation of Antimicrobial Resistance - Released August 2004 |
|
Guidance for Industry #144 - Pre-Approval Information for Registration of New Veterinary Medicinal Products for Food-Producing Animals with Respect to Antimicrobial Resistance - VICH GL27, Final Guidance, April 27, 2004 | doc | | pdf | |
|
Guidance for Industry 152 - Evaluating the Safety of
Antimicrobial New Animal Drugs with Regard to Their Microbiological
Effects on Bacteria of Human Health Concern, October 23,
2003 | doc | |
pdf |
|
|
Enrofloxacin
for Poultry: Withdrawal of Approval of Bayer Corporation’s
New Animal Drug Application (NADA) 140-828 (Baytril),
Docket No. 00N-1571 |
|
Guidance for Industry #144- Pre-Approval Information
for Registration of New Veterinary Medicinal Products
for Food-Producing Animals with Respect to Antimicrobial
Resistance, VICH GL27, Draft Guidance - June 12, 2003
| doc | | pdf
| |
|
CVM and Judicious Use of Antimicrobials |
|
FDA
Task Force on Antimicrobial Resistance: Key Recommendations
and Report, December 2000 |
|
Effect of the Use of Antimicrobials
in Food-Producing Animals on Pathogen Load: Systematic
Review of the Published Literature, October 2000
| PathRpt.doc
| | PathTables.xls (Tables
1,2,3 and 4) |
| PathFigure.doc | |
|
Guidance for Industry #121: Expedited Review for New
Animal Drug Applications for Human Pathogen Reduction
Claims, March 6, 2001 | doc
| | pdf | |
|
An Approach for Establishing Thresholds in Association
with the Use of Antimicrobial Drugs in Food-Producing
Animals, December 19, 2000 | doc
| | pdf | |
|
Important Notice:
Working @RISK model of the analysis described in the
report of "The human health impact of fluoroquinolone
resistance Campylobacter associated with the consumption
of chicken." Please note that despite the *.xls extension,
this file will not be functional and will not have numeric
values printed in all the cells unless the user opens
it with @RISK 4.0. If the user does not have this software
available, opening the file in Excel will allow the user
to see input data values and the functions that were used
to generate intermediary and final outputs of the model.
The output cells, however, will contain "#NAME?" because
the @RISK 4.0 functions will be unknown to Excel.
@Risk Model - Analysis of the human health
effect of fluoroquinolone resistant Campylobacter in domestically
reared and consumed broilers |
|
Risk Assessment on the Human Health Impact of Fluoroquinolone Resistant
Campylobacter Associated with the Consumption of Chicken,
dated October 18, 2000,
Revised January 5, 2001 |
|
Antibiotic Resistance in Livestock, USDA/HHS
Response to the House and Senate Reports: Agriculture,
Rural Development, Food and Drug Administration, and Related
Agencies, Appropriations Bill, 2000, September 14, 2000
(pdf) |
|
Public
Health Action Plan to Combat Antimicrobial Resistance,
Centers for Disease Control and Prevention, January 2000
|
|
Human-Use Antibiotics in Livestock Production;
HHS Response to House Report 106-157 - Agriculture, Rural
Development, Food and Drug Administration, and Related
Agencies, Appropriations Bill, 2000, April 28, 2000 |
|
Risk Assessment of the Public Health Impact of Streptogramin
Resistance in Enterococcus faecium Attributable to the
Use of Streptogramins in Animals; Request for Comments
and for Scientific Data and Information. | pdf | | txt | |
Web page updated by mdt, September 20, 2004, 2:00 PM ET
|
|